ACR volunteers from the areas of Economics, IT, Quality and Safety as well as our Lung Cancer Screening Committee will be converging on Washington D.C. on June 19, 2014, for a series of meetings with the Centers for Medicare & Medicaid Services (CMS). In two separate sessions, we will be making the case for coverage of lung cancer screening with low-dose CT (LDCT) scanning and also helping the Agency as it decides how best to comply with the legislative mandate to incorporate Clinical Decision Support into the ordering of advanced imaging starting in 2017.
While the meetings on these two important topics are different, many of the overarching themes that inform our approach are one and the same. We have embraced the Imaging 3.0™ principle that we want to see all the imaging performed that is appropriate and beneficial and none that is not.
The rigorous standards that we have set for ourselves in our Designated Lung Screening Center program will, we trust, make it clear to CMS that despite erroneous claims made by the MEDCAC panel, radiologists are committed to implementing this important new program in a safe manner that will save thousands of lives every year.
The 20 years of volunteer work and cross-specialty collaboration that are the foundation of the ACR Appropriateness Criteria® are a powerful example of our specialty’s commitment to quality. CMS has much latitude and little experience in the implementation of the legislation and we hope they will accept our offer to support and guide them in the best interests of the patients we both serve.
Geraldine B. McGinty, MD, MBA, FACR